124 related articles for article (PubMed ID: 25557298)
1. Preparation and evaluation of a novel biodegradable long-acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathy.
Zhang X; Wei J; Ma P; Mu H; Wang A; Zhang L; Wu Z; Sun K
J Pharm Pharmacol; 2015 Feb; 67(2):160-9. PubMed ID: 25557298
[TBL] [Abstract][Full Text] [Related]
2. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y
Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
[TBL] [Abstract][Full Text] [Related]
3. [Study on preparation of ligustrazine ocular implant and correlation between in vivo and in vitro drug release].
Wei JH; Li P; Ma PK; Mu HJ; Chen DQ; Sun KX
Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1160-4. PubMed ID: 23944029
[TBL] [Abstract][Full Text] [Related]
4. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.
Giordano GG; Refojo MF; Arroyo MH
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2743-51. PubMed ID: 8344796
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
[TBL] [Abstract][Full Text] [Related]
6. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l-lactide-co-glycolide) or polycaprolactone.
Stein S; Auel T; Kempin W; Bogdahn M; Weitschies W; Seidlitz A
Eur J Pharm Biopharm; 2018 Jun; 127():270-278. PubMed ID: 29490233
[TBL] [Abstract][Full Text] [Related]
7. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.
Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
Wang G; Tucker IG; Roberts MS; Hirst LW
Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
[TBL] [Abstract][Full Text] [Related]
9. An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.
Cardillo JA; Farah ME; Mitre J; Morales PH; Costa RA; Melo LA; Kuppermann B; Jorge R; Ashton P
Br J Ophthalmol; 2004 Sep; 88(9):1201-5. PubMed ID: 15317716
[TBL] [Abstract][Full Text] [Related]
10. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid.
Dong X; Chen N; Xie L; Wang S
Retina; 2006 Feb; 26(2):210-3. PubMed ID: 16467680
[TBL] [Abstract][Full Text] [Related]
11. [Antiproliferative effect of sustained drug delivery system of all-trans retinoic acid implant into rabbit's vitreous cavity for treatment of proliferative vitreoretinopathy].
Yan XR; Dong XG; Chen N; Wang W
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):621-5. PubMed ID: 14766078
[TBL] [Abstract][Full Text] [Related]
12. Effect of Biodegradable Scleral Plugs Containing Curcumin on Proliferative Vitreoretinopathy.
Zhang J; Zhou N; Zhang B; Ma J
Ophthalmic Res; 2018; 59(1):30-36. PubMed ID: 28942445
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.
Ramchandani M; Robinson D
J Control Release; 1998 Jul; 54(2):167-75. PubMed ID: 9724903
[TBL] [Abstract][Full Text] [Related]
14. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
15. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
[TBL] [Abstract][Full Text] [Related]
16. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
[TBL] [Abstract][Full Text] [Related]
18. In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants.
Yavuz B; Bozdağ Pehlivan S; Kaffashi A; Çalamak S; Ulubayram K; Palaska E; Çakmak HB; Ünlü N
Drug Deliv; 2016 Nov; 23(9):3279-3284. PubMed ID: 27027148
[TBL] [Abstract][Full Text] [Related]
19. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
Cho KY; Lee S; Park JK
Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
[TBL] [Abstract][Full Text] [Related]
20. An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.
Yang CS; Khawly JA; Hainsworth DP; Chen SN; Ashton P; Guo H; Jaffe GJ
Arch Ophthalmol; 1998 Jan; 116(1):69-77. PubMed ID: 9445210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
